|
RU2744162C1
|
|
Analgesic agent based on 5-(2-aminopropyl)-6-oxo-3,4-diphenylpyrrolo[3,4-c]pyrazole
|
|
RU2746366C1
|
|
Antibiotic prophylaxis method in the perioperative period of postoperative pyoinflammatory complications
|
|
RU2717246C1
|
|
Ethyl 4-(5-benzoyl-6-(4-(diethylamino)phenyl)-4-hydroxy-2-thioxohexahydropyrimidin-4-carboxamino)benzoate, exhibiting analgesic and anti-inflammatory action
|
|
RU2706357C1
|
|
Silver salts of 3,4-diaryl-5-[4-(acetylaminosulphonyl)phenyl]-4,6-dihydropyrrolo[3,4-c]pyrazol-6-ones exhibiting antifungal activity
|
|
RU2723897C2
|
|
2-hydroxy-n-(6-methoxybenzo[d]thiazol-2-yl)-4-oxo-4-phenylbut-2-enamide, having gastroprotective and immunomodulatory action
|
|
RU2717243C2
|
|
3-bromo-4-(4-methoxyphenyl)-n-(5-methyl-1,3,4-thiadiazol-2-yl)-2,4-dioxobutanamide, having antimicrobial action
|
|
RU2717242C2
|
|
Tris {[1-(6-methylbenzo[d]thiazol-2-yl)amino-1,4-dioxo-4-(p-tolyl) but-2-en-2-yl]oxy} iron having anti-inflammatory action
|
|
RU2717247C2
|
|
Method of selecting anti-inflammatory agents in series of anthranilic acid derivatives using design constants of lipophilicity and ionisation
|
|
RU2706365C2
|
|
Search for biologically active substances with anti-inflammatory action on binding energy with cyclooxygenases 1 and 2
|
|
RU2679892C1
|
|
4-methylphenylamide n-benzoyl-5-bromo anthranic acid with anti-inflammatory activity
|
|
RU2706366C2
|
|
Method of selecting anti-inflammatory agents using calculated energies of interaction with enzymes cyclooxygenase 1 and 2
|
|
RU2679450C2
|
|
2-(4-methoxyphenylamino)-4-(2,4-dimethylphenyl)-1-(piperazin-1-yl)but-2-ene-1,4-dione hydrochloride with hemostatic activity
|
